Cargando…

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers

Prospective biomarker studies can be used to identify biomarkers predictive of disease onset. However, if serum biomarkers are measured years after their collection, the storage conditions might affect analyte concentrations. Few data exists concerning which metabolites and proteins are affected by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valo, Erkka, Colombo, Marco, Sandholm, Niina, McGurnaghan, Stuart J., Blackbourn, Luke A. K., Dunger, David B., McKeigue, Paul M., Forsblom, Carol, Groop, Per-Henrik, Colhoun, Helen M., Turner, Charles, Dalton, R. Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930974/ https://www.ncbi.nlm.nih.gov/pubmed/35301383 http://dx.doi.org/10.1038/s41598-022-08429-0

Ejemplares similares

Biomarker panels associated with progression of renal disease in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2019)

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
por: Sandholm, Niina, et al.
Publicado: (2018)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Rate of Kidney Function Decline is Associated With Kidney and Heart Failure in Individuals With Type 1 Diabetes
por: Sandholm, Niina, et al.
Publicado: (2023)

Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes
por: Mutter, Stefan, et al.
Publicado: (2021)

Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2020)

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics
por: Iakovliev, Andrii, et al.
Publicado: (2023)

Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes
por: Haukka, Jani K., et al.
Publicado: (2018)

Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
por: Pongrac Barlovic, Drazenka, et al.
Publicado: (2020)

Development and validation of a cardiovascular risk prediction model in type 1 diabetes
por: McGurnaghan, Stuart J., et al.
Publicado: (2021)

Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations
por: Sandholm, Niina, et al.
Publicado: (2022)

Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status
por: Parente, Erika B., et al.
Publicado: (2020)

Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes
por: Härma, Mari-Anne, et al.
Publicado: (2020)

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study
por: Ochs, Andreas, et al.
Publicado: (2019)

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis
por: McGurnaghan, S., et al.
Publicado: (2018)

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
por: Mair, Colette, et al.
Publicado: (2019)

Flash monitor initiation is associated with improvements in HbA(1c) levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study
por: Jeyam, Anita, et al.
Publicado: (2021)

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
por: Höhn, Andreas, et al.
Publicado: (2021)

Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
por: Colombo, Marco, et al.
Publicado: (2019)

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017
por: O’Reilly, Joseph E., et al.
Publicado: (2020)

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland
por: McGurnaghan, Stuart J., et al.
Publicado: (2022)

Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018
por: Höhn, Andreas, et al.
Publicado: (2022)

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
por: McKeigue, Paul M., et al.
Publicado: (2019)

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study
por: Bell, Samira, et al.
Publicado: (2017)

Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes
por: Wadén, Jenny M., et al.
Publicado: (2019)

Genetic and epigenetic background of diabetic kidney disease
por: Sandholm, Niina, et al.
Publicado: (2023)

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland
por: Jeyam, Anita, et al.
Publicado: (2021)

Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes
por: Syreeni, Anna, et al.
Publicado: (2019)

Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes
por: Syreeni, Anna, et al.
Publicado: (2011)

Serum kidney injury molecule 1 and β(2)-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
por: Colombo, Marco, et al.
Publicado: (2018)

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study
por: McKeigue, Paul M., et al.
Publicado: (2020)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups
por: Lithovius, Raija, et al.
Publicado: (2023)

Mapping activities on climate and health to the essential public health operations (EPHO)
por: McGurnaghan, P, et al.
Publicado: (2023)

Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
por: Harjutsalo, Valma, et al.
Publicado: (2011)

CACNB2 Is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes
por: Vuori, Nadja, et al.
Publicado: (2019)

Genetic factors affect the susceptibility to bacterial infections in diabetes
por: Simonsen, Johan R., et al.
Publicado: (2021)

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study
por: Vadiveloo, Thenmalar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qhqj2949ir8cdfnpnquq7i29hr